BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37793752)

  • 1. Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review.
    Greco A; Occhipinti G; Giacoppo D; Agnello F; Laudani C; Spagnolo M; Mauro MS; Rochira C; Finocchiaro S; Mazzone PM; Faro DC; Landolina D; Ammirabile N; Imbesi A; Raffo C; Capodanno D
    J Am Coll Cardiol; 2023 Oct; 82(15):1538-1557. PubMed ID: 37793752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.
    Bhatia K; Ladd LM; Carr KH; Di Napoli M; Saver JL; McCullough LD; Hosseini Farahabadi M; Alsbrook DL; Hinduja A; Ortiz Garcia JG; Sabbagh SY; Jafarli A; Divani AA
    Curr Neurol Neurosci Rep; 2023 May; 23(5):235-262. PubMed ID: 37037980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic drug treatment of pediatric patients with ischemic stroke.
    Nowak-Göttl U; Sträeter R; Sébire G; Kirkham F
    Paediatr Drugs; 2003; 5(3):167-75. PubMed ID: 12608881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease.
    Welsh RC; Peterson ED; De Caterina R; Bode C; Gersh B; Eikelboom JW
    Am Heart J; 2019 Dec; 218():100-109. PubMed ID: 31715433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic medication for stroke prevention.
    Weimar C; Weber R; Diener HC
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1245-54. PubMed ID: 19814667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy in aortic diseases: A narrative review.
    Caron F; Anand SS
    Vasc Med; 2017 Feb; 22(1):57-65. PubMed ID: 28215108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern strategies for the management of patients who have suffered ischemic stroke or transient ischemic attack].
    Shirokov EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12. Vyp. 2):61-67. PubMed ID: 38148699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic strategy in stroke.
    Bousser MG
    Thromb Haemost; 2001 Jul; 86(1):1-7. PubMed ID: 11486994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update on antithrombotic secondary prevention of ischemic stroke].
    Köhrmann M; Kleinschnitz C
    Nervenarzt; 2019 Oct; 90(10):995-1004. PubMed ID: 31560112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of antithrombotics in secondary stroke prevention.
    Lazzaro MA; Malhotra K; Mohammad YM
    Semin Neurol; 2010 Nov; 30(5):492-500. PubMed ID: 21207341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New opportunities to optimize antithrombotic therapy for secondary stroke prevention.
    Kim AS; Easton JD
    Int J Stroke; 2019 Apr; 14(3):220-222. PubMed ID: 30722755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombotic drugs in the prevention of ischemic stroke].
    Bousser MG
    J Mal Vasc; 2005 Dec; 30(5):267-79. PubMed ID: 16439939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.
    Kaplan ED; Sacco RL
    Curr Neurol Neurosci Rep; 2002 Jan; 2(1):31-7. PubMed ID: 11898580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic drugs for carotid artery dissection.
    Lyrer P; Engelter S
    Cochrane Database Syst Rev; 2000; (4):CD000255. PubMed ID: 11034680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic treatment in the prevention of ischemic stroke.
    Emre U; Rantanen K; Tatlisumak T
    Curr Drug Targets; 2007 Jul; 8(7):817-23. PubMed ID: 17630934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic Therapy for Stroke Patients with Cardiovascular Disease.
    Gusdon AM; Farrokh S; Grotta JC
    Semin Neurol; 2021 Aug; 41(4):365-387. PubMed ID: 33851394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.